相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review article: infliximab for Crohn's disease treatment - shifting therapeutic strategies after 10 years of clinical experience
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Validating Crohn's Disease Activity Indices for Use in Assessing Postoperative Recurrence
T. D. Walters et al.
INFLAMMATORY BOWEL DISEASES (2011)
Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon
Michael Dam Jensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
How Rapidly Should Remission Be Achieved?
Kim L. Isaacs
DIGESTIVE DISEASES (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2010)
Fecal Calprotectin Variability in Crohn's Disease
Bjorn Moum et al.
INFLAMMATORY BOWEL DISEASES (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease
CY Su et al.
GASTROENTEROLOGY (2004)
Review article: Crohn's disease: monitoring disease activity
R Sostegni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
分享论文
